To determine whether adipocyte-secreted lipid molecules and their uptake in cancer cells via FATP2 are responsible for the observed OV resistance, we treated FATP2-mediated fatty acid accumulation with a small molecule inhibitor. The gene discussed is SLC27A2; the disease is cancer.